scholarly journals Randomized clinical trial to evaluate ferric carboxymaltose and iron sucrose for treatment of postpartum anaemia in a tertiary hospital

2018 ◽  
Vol 7 (11) ◽  
pp. 4551
Author(s):  
Sheela H. S. ◽  
Ashwini Neelakanthi ◽  
Nikitha C. P.
Keyword(s):  
Intravenous Iron ◽  
Tertiary Hospital ◽  
Iron Sucrose ◽  
Ferric Carboxymaltose ◽  
Treatment Groups ◽  
Baseline Haemoglobin ◽  
Target Haemoglobin ◽  
Calculated Dose ◽  
Iron Delivery

Background: Ferric carboxymaltose and iron sucrose are two iron carbohydrate complexes optimized for iron delivery and extensively used in postpartum anaemia. This study compares the efficacy and safety of ferric carboxymaltose with that of iron sucrose in patients with postpartum anaemia.Methods: One hundred women diagnosed with postpartum anaemia were randomized prospectively in a 1:1 ratio to receive either ferric carboxymaltose or iron sucrose. Fifty patients received intravenous iron carboxymaltose depending on the iron deficit at rate of 1000 mg/week and fifty patients received intravenous iron sucrose at a rate of 200 mg/day on alternate days till the calculated dose is given.Results: Fifty patients were enrolled in each treatment group. Both groups showed increases in mean haemoglobin from baseline at 2 weeks and 6 weeks. The increase in haemoglobin was significantly higher in ferric carboxymaltose group compared to iron sucrose at both week 2 (2.64±0.91 versus 2.17±0.76; p=0.010) and week 6 timepoints (4.65±1.17 versus 3.96±1.06; p=0.005). The proportion of patients achieving target haemoglobin of 12 gm/dl was significantly higher in ferric carboxymaltose group compared to iron sucrose at week 6 (77.3% versus 50.0%; p=0.013). The incidence of adverse events was similar across treatment groups and no specific safety concerns were observed.Conclusions: Both ferric carboxymaltose and iron sucrose caused increase in baseline haemoglobin. Ferric carboxymaltose had significantly higher increases in haemoglobin compared to iron sucrose at both follow up timepoints (week 2 and week 6). It was more likely to achieve target haemoglobin with ferric carboxymaltose within 6 weeks compared to iron sucrose. Ferric carboxymaltose may be considered in women with postpartum anaemia for faster rise in haemoglobin while requiring fewer injections compared to iron sucrose.

scholarly journals A study for efficacy and safety of ferric carboxymaltose versus iron sucrose in iron deficiency anemia among pregnant women in tertiary care hospital

2019 ◽  
Vol 8 (6) ◽  
pp. 2280
Author(s):  
Divyani Agrawal ◽  
Deepa Lokwani Masand
Keyword(s):  
Iron Deficiency ◽  
Adverse Events ◽  
Pregnant Women ◽  
Iron Deficiency Anemia ◽  
Intravenous Iron ◽  
Iron Sucrose ◽  
Deficiency Anemia ◽  
Ferric Carboxymaltose ◽  
Efficacy And Safety ◽  
Anemia During Pregnancy

Background: Anemia is one of the common manageable problem among the pregnant women worldwide, which contributes to maternal and perinatal mortality. This study aims to compare the efficacy and safety of intravenous ferric carboxymaltose with intravenous iron sucrose in treating anemia during pregnancy. Objective of this study was to compare safety and efficacy of intravenous ferric carboxymaltose with intravenous ferric sucrose in iron deficiency anemia during pregnancy.Methods: It’s an interventional prospective study conducted in Department of Obstetrics and Gynecology at NIMS, Jaipur, Rajasthan, India constituting of 100 pregnant women. Group 1- 50 pregnant women were treated with intravenous ferric carboxymaltose and Group 2: 50 pregnant women were treated with intravenous iron sucrose. Hemoglobin and serum ferritin levels were measured pre and post treatment with parenteral iron therapy. The efficacy of intravenous ferric carboxymaltose in comparison to intravenous iron sucrose was assessed. The evaluation of safety and tolerance with the parenteral therapy was also performed.Results: Anemia during pregnancy was more prevalent among the reproductive age group and in multiparous women. The mean rise in the hemoglobin level with ferric carboxymaltose was 2.92 gm/dl and with that of iron, sucrose was 1.08 gm/dl. The man rise in the serum ferritin levels with ferric carboxymaltose was 64.97ng/ml and with iron sucrose was 31.64 ng/ml. Ferric carboxymaltose was observed to be safer with no adverse events in comparison to the Iron sucrose which was related with adverse events among 03 pregnant women.Conclusions: Intravenous ferric carboxymaltose was more efficacious and safer in comparison to intravenous iron sucrose among pregnant women. Hence, ferric carboxymaltose is the drug of choice in treatment of iron deficiency anemia during pregnancy.

scholarly journals Study of efficacy of intravenous iron sucrose therapy in iron deficiency anaemia of pregnancy

2013 ◽  
Vol 11 (2) ◽  
pp. 107-110
Author(s):  
M Vijayasree
Keyword(s):  
Iron Deficiency ◽  
Gestational Age ◽  
Economic Status ◽  
Intravenous Iron ◽  
Lower Class ◽  
Iron Sucrose ◽  
Deficiency Anemia ◽  
P Value ◽  
Economic Class ◽  
Target Haemoglobin

Background: Anaemia is the most common medical disorder in pregnancy and is responsible for higher of the maternal deaths in the developing countries. Objective: To determine the efficacy of intravenous iron sucrose, in anemic pregnant women, presenting at Mamata General Hospital, Khammam. Methods: Fifty patients with proved iron deficiency anemia having haemoglobin between 8-10gm% were included in the study. Total iron deficit was calculated by standard formula. Target haemoglobin to be achieved was 11gm%. Iron sucrose was administered by intravenous infusion in divided doses. Haemoglobin was repeated 3 weeks after the last dose of intravenous iron sucrose. Gestational Age, Socio economic class distribution was calculated in percentage , Pre and post treatment Hb% was calculated by mean and standard deviation and P-value was Assessed. Results: Majority of the patients i.e. 60% had gestational age between 32-34 weeks, 30% were in between 29-31 weeks of gestational age while 10% were between 26-28 weeks gestation. The Mean gestational age was 32.4±2.7. Distribution of cases by socio economic status showed, 40% belonged to lower class, 32% belonged to middle class and 28% were from upper class. Intravenous iron sucrose therapy was effective in 90% of the patients without any side effects. There were no allergic reactions. Conclusion: This study showed a significant improvement in the haemoglobin of the patients who received iron sucrose infusion. Patients achieved the target of 11 gram % haemoglobin. It was safe and well tolerated. Health Renaissance, January-April 2013; Vol. 11 No.1; 107-110 DOI: http://dx.doi.org/10.3126/hren.v11i2.8216

scholarly journals Comparative study of efficacy and safety of intravenous ferric carboxymaltose versus iron sucrose in treatment of post-partum anemia

2021 ◽  
Vol 10 (9) ◽  
pp. 3531
Author(s):  
Ragvi Raman ◽  
Jayanthy T. ◽  
Apoorva Asranna
Keyword(s):  
Iron Deficiency Anaemia ◽  
Intravenous Iron ◽  
Post Treatment ◽  
Iron Sucrose ◽  
Ferric Carboxymaltose ◽  
Postpartum Women ◽  
Deficiency Anaemia ◽  
Group A ◽  
The Mean ◽  
Group B

Background: Ferric carboxymaltose has been recently introduced for the treatment of anaemia. The present study was planned to compare the efficacy, tolerability and safety of intravenous ferric carboxymaltose with intravenous iron sucrose in the treatment of iron deficiency anaemia among postpartum women.Methods: A total of 60 postpartum women with haemoglobin levels between 7-10 g/dl were randomized into two groups: 30 in group A (received iron carboxymaltose) and 30 in group B (Received iron sucrose). Haemoglobin and serum ferritin levels were done on day 0 and after 6 weeks.Results: The post treatment haemoglobin levels were found to be 10-10.9 g/dl in 66.7% of women in group A and 63.3% in group B. The mean post treatment haemoglobin levels in group A was 9.97±0.3 g/dl and in group B was 10.9 g/dl (p<0.001). The mean increase in haemoglobin levels post treatment were significantly high in group B (2.1±0.5 gm%) compared to group A (1.3±0.5 gm%). The mean post treatment S. Ferritin levels in group A was 91.2±25.8 and in group B was 126.5±23.2 gm%. The mean increase in S. Ferritin levels post treatment were significantly high in group B (96.9±23.3) compared to group A (62.7±22.6) (p<0.001).Conclusions: Intravenous iron carboxymaltose is more effective and better tolerated in the treatment of iron deficiency anaemia among postpartum women compared to intravenous iron sucrose.

scholarly journals Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose

2012 ◽  
Vol 40 (5) ◽  
Author(s):  
Patricia Christoph ◽  
Christine Schuller ◽  
Hanna Studer ◽  
Olivier Irion ◽  
Begoña Martinez De Tejada ◽  
...  
Keyword(s):  
Intravenous Iron ◽  
Iron Sucrose ◽  
Ferric Carboxymaltose ◽  
High Dose ◽  
Iron Treatment ◽  
In Pregnancy

scholarly journals Comparison of efficacy of injection ferric carboxymaltose and iron sucrose in moderate anaemia in pregnancy

2021 ◽  
Vol 10 (7) ◽  
pp. 2794
Author(s):  
Kishna Ram ◽  
Kavita Arya ◽  
Nupur Hooja ◽  
Neha Singh ◽  
Aditi Jaiswal
Keyword(s):  
Intravenous Iron ◽  
Gastrointestinal Disorder ◽  
Oral Iron ◽  
Iron Sucrose ◽  
Ferric Carboxymaltose ◽  
Group A ◽  
High Doses ◽  
Anaemia In Pregnancy ◽  
Group B ◽  
Group Target

Background: Prevalence of anaemia in pregnant women is 14% in developed and 58-89.6% in pregnant Indian women. Parenteral iron is seems to be an option in the treatment of moderate iron deficiency anaemia which allow high doses of iron to be administered rapidly, in those who are intolerant to oral iron, have  poor compliance to oral iron or gastrointestinal disorder. The objective was to compare the efficacy of newer drug, inravenous ferric carboxymaltose (FCM) with intravenous iron sucrose.Methods: Group A were given injection FCM and group B were given injection iron sucrose. FCM was given in one or two sittings depending on iron requirement and iron sucrose was given in divided doses. Haemogram was done at baseline and on day 3 and 21 and at 12 weeks. All the observations were tabulated and analysed.Results: The mean rise in haemoglobin values from baseline in the FCM group was 0.20±0.06 at 3rd day, 2.03±0.47 at 3 weeks, 3.86±0.53 at 12 weeks compared to iron sucrose group, which was 0.11±0.08 at 3rd day, 1.51±0.39 at 3 weeks, and 3.22±0.54 at 12 weeks, which was statistically significant and showed that the haemoglobin levels were increased more in FCM group. Target haemoglobin was achieved in 92% women in FCM group and 78% women in iron sucrose group.Conclusions: Women in the FCM group achieved significantly higher haemoglobin level than in iron sucrose group. It was given in fewer sittings, hence was more convenient with better efficacy.

Sign in / Sign up

Export Citation Format

Share Document